Nutraplus India reported a net loss of ₹0.37 crore for Q2 FY26 on minimal income. The company faces severe financial distress with negative equity and an auditor's qualified report citing non-compliance and missing data.

Nutraplus India Posts ₹0.37 Crore Loss Amid Auditor Concerns

Nutraplus India reported a net loss of ₹(0.3651) crore (₹36.51 lakh) for the quarter ended September 30, 2025. The company's total income for the period stood at a mere ₹0.0067 crore (₹0.67 lakh).

Reader Takeaway: Persistent financial losses and significant auditor concerns highlight severe going-concern risks for shareholders.

What just happened

Nutraplus India has disclosed its financial results for the second quarter of the fiscal year 2025-26. The company recorded a net loss of ₹0.3651 crore against a very low total income of ₹0.0067 crore. Expenses for the quarter amounted to ₹0.4563 crore.

Why this matters

The results reveal a company in deep financial trouble. The substantial net loss, coupled with a negative net worth indicated by the negative total equity of ₹(5.7152) crore, suggests a precarious financial position. Liabilities significantly outweigh assets, with total current liabilities at ₹8.4853 crore and non-current liabilities at ₹2.2274 crore.

The backstory

Adding to the concerns, the company's independent auditor, Raman S. Shah & Associates, issued a qualified limited review report. This report highlighted significant issues, including the company's failure to comply with SEBI regulations and the Companies Act, 2013. The auditor also noted that the company's inability to provide timely financial data critically impaired their review process.

Furthermore, the company lost all its property, plant, and equipment under the SARFEASI Act, 2002, after it was declared a non-performing asset (NPA) in FY 2019-20. Although bank auction procedures were delayed, leading to its continued listing, the manufacturing infrastructure is gone.

What changes now

The revised filing, submitted after a query from the BSE, indicates ongoing issues with internal controls and regulatory compliance. The findings suggest a company struggling with basic operational and reporting functions, posing significant governance risks.

Risks to watch

The primary risks for investors include the company's severely negative net worth, the complete loss of its manufacturing assets, and the auditor's strong reservations due to non-cooperation and non-compliance. The going-concern status of the company is highly questionable.

Peer comparison

No direct peer comparison is available as the company's financial health and operational status are critically impaired, unlike typical listed entities in the sector.

Context metrics (time-bound)

• Quarter ended September 30, 2025: Net Loss ₹(0.3651) crore, Total Income ₹0.0067 crore.
• As of September 30, 2025: Total Equity ₹(5.7152) crore, Cash & Equivalents ₹0.0641 crore.

What to track next

Investors should closely monitor any further communications from the company or the BSE regarding compliance efforts, any potential restructuring plans, or regulatory actions. The ability of the company to rectify its financial reporting and compliance issues will be critical.